Abstract

This article explores the fundamental importance of implementing rapid tests in the diagnosis of dengue, emphasizing their essential role in early detection and efficient management of this mosquito-transmitted disease. These tests, based on the detection of viral antigens or specific antibodies, not only provide results in record time but also constitute a significant contribution to global healthcare. Rapid tests offer an immediate response, allowing timely medical intervention that can make a difference in the clinical course of the patient. Their ability to identify the virus in the early stages of infection is crucial, not only for individualized care but also for mitigating the spread of dengue at the community level. Moreover, by distinguishing between virus serotypes, these tests provide a more precise perspective for the application of therapeutic and preventive strategies. The accessibility and simplicity of rapid tests become key elements for their positive impact, especially in resource-limited settings. The swift availability of results not only accelerates clinical decision-making but also facilitates the collection of crucial epidemiological data. This information contributes to the strategic planning of public health authorities, enabling a coordinated and efficient response to dengue outbreaks and epidemics. The widespread adoption of rapid tests in dengue diagnosis emerges as a fundamental pillar in global healthcare. Their ability to provide rapid and accurate results, their role in early detection, and their contribution to efficient management make these tests an invaluable tool in the fight against this prevalent disease, redefining how we approach the diagnosis and treatment of dengue on a global scale.